Developing medicines for tropical diseases
60° Pharmaceuticals (60P) was founded with the goal of developing medicines for tropical diseases, including those considered neglected by the World Health Organization. Malaria and dengue fever are on this list, but despite competitive drug development pipelines for these diseases, critical gaps remain.
60P is focused on drug development for therapeutic methods left unaddressed by the established research and development networks. In order to improve overall return on investment, 60P will also invest in products for tropical diseases targeted at market segments in industrialized countries.